Virbac
Develops animal health pharma, vaccines & diagnostics for vets, farmers & pet owners globally.
FR000 | PA
Overview
Corporate Details
- ISIN(s):
- FR0000031577
- LEI:
- 969500QQ1X5XHG649644
- Country:
- France
- Address:
- 1ERE AVENUE, 06510 CARROS
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company develops, manufactures, and distributes a comprehensive range of products and services for veterinarians, farmers, and pet owners. Operating in over 100 countries, its portfolio offers innovative solutions covering the majority of animal species and diseases. Key product areas include pharmaceuticals, vaccines, parasite control, dental care, nutritional supplements, and diagnostic tools, all aimed at shaping the future of animal health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-12 17:45 |
Earnings Release
VIRBAC: résultats semestriels 2025
|
French | 1.2 MB | ||
| 2025-09-12 17:45 |
Earnings Release
Virbac: 2025 Half-year results
|
English | 1.1 MB | ||
| 2025-09-12 17:30 |
Interim Report
Virbac : Rapport financier semestriel 2025
|
French | 13.2 MB | ||
| 2025-09-12 17:30 |
Interim Report
Virbac : Half-yearly financial report 2025
|
English | 13.4 MB | ||
| 2025-09-12 17:30 |
Report Publication Announcement
Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30…
|
French | 264.9 KB | ||
| 2025-09-12 17:30 |
Report Publication Announcement
Virbac : Public release of the Half-Year Financial Report at 30 June 2025.
|
English | 264.6 KB | ||
| 2025-08-18 09:30 |
Remuneration Information
VIRBAC: Informations sur les conditions de rémunération de Paul Martingell
|
French | 80.5 KB | ||
| 2025-08-18 09:30 |
Remuneration Information
Virbac:: Paul Martingell's compensation terms
|
English | 128.7 KB | ||
| 2025-06-19 08:30 |
Board/Management Information
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septemb…
|
French | 271.7 KB | ||
| 2025-06-19 08:30 |
Board/Management Information
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effecti…
|
English | 279.3 KB | ||
| 2025-06-10 09:59 |
Declaration of Voting Results & Voting Rights Announcements
Virbac : Declaration of the number of share and voting rights 05/2025
|
English | 59.2 KB | ||
| 2025-06-10 09:59 |
Declaration of Voting Results & Voting Rights Announcements
Virbac : Déclaration d'actions et de droits de vote 05/2025
|
French | 36.6 KB | ||
| 2025-05-26 10:05 |
Pre-Annual General Meeting Information
VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consulta…
|
French | 26.3 KB | ||
| 2025-05-07 16:27 |
Declaration of Voting Results & Voting Rights Announcements
Virbac : Déclaration d'actions et de droits de vote 04/2025
|
French | 36.6 KB | ||
| 2025-04-28 19:00 |
Annual Report (ESEF)
Virbac : Rapport Annuel Virbac au 31 décembre 2024 (ESEF)
|
French | 22.1 MB |
Automate Your Workflow. Get a real-time feed of all Virbac filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Virbac via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-17 | N/A | Other | Sell | 370 | 135,790.00 EUR |
| 2023-07-19 | N/A | Other | Buy | 950 | 245,100.00 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
